Essential fatty acid depletion in children with inflammatory bowel disease

References

• Decsi T, Zaknun D, Zaknun J, Sperl W, Koletzko B. Long-chain polyunsaturated fatty acids in children with severe protein-energy malnutrition without and with human immunodeficiency virus-1 infection. Am J Clin Nutr 1995;62: 1283–8.
   Google Scholar
• Decsi T, Molnar D, Koletzko B. The effect of under- and overnutrition on essential fatty acid metabolism in childhood. Eur J Clin Nutr 1998;52:541–8.
   Google Scholar
• Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W. Dietary supplementation with fish oil in ulcerative colitis. Annals Int Med 1992;116:609–14.
   Google Scholar
• Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 1996;334: 1557–60.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone mineral density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Min Res 1995;10:250–6.
   PubMed Web of Science ®Google Scholar
• Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. JPGN 1994;19:7–21.
   Google Scholar
• Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33:1365–3.
   Google Scholar
• Esteve-Comas M, Nunez MC, Fernandes-Banares F, Abad-Lacruz A, Gil A, Cabre E, et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993;34:1370–3.
   Google Scholar
• Trebble TM, Wootton SA, May A, Erlewyn-Lajeunesse MD, Chakraborty A, Mullee MA, et al. Essential fatty acid status in pediatric Crohn’s disease: relationship with disease activity and nutritional status. Aliment Pharmacol Ther 2003;18: 433–42.
   Google Scholar
• Hyams JS, Ferry GD, Mandel FS. Development and validation of pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr 1991;12: 439–47. 2003;18: 433–42.
   Google Scholar
• Trulove SC, Witts LJ. Cortisone in ulcerative colitis: final report on therapeutic trial. Br Med J 1955;2:1041–8.
   PubMed Web of Science ®Google Scholar
• Socha P, Koletzko B, Pawlowska P, Socha J. Essential fatty acid status in children with cholestasis, in relation to serum bilirubin concentration. J Pediatr 1997;131:700–6.
   PubMed Web of Science ®Google Scholar
• Cole TJ, Donnet ML, Stanfield JP. Weight-for-height indices to assess nutritional status: a new index on a slide-rule. Am J Clin Nutr 1981;34:1935–43.
   Google Scholar
• Bhatia SJ, Moffitt SD, Goldsmith MA, Bain RP, Kutner MH, Rudman D. A method of screening for growth hormone deficiency using anthropometrics. Am J Clin Nutr 1981;34:281–8.
   PubMed Web of Science ®Google Scholar
• Kurniewicz-Witczakowa R. Rozwoj fizyczny dzieci i mlodziezy warszawskiej [Anthropometry of children and adolescents in Warsaw]. Warszawa: IMiD; 1983.
   Google Scholar
• De Leenheer AP, De Bevere VORC, De Ruyter MGM, Claeys AE. Simultaneous determination of retinol and α-tocopherol in human serum by high-performance liquid chromatography. J Chromatogr 1979;162:408–13.
   PubMed Web of Science ®Google Scholar
• Koletzko B, Schmidt E, Bremer HJ, Haug M, Harzer G. Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants. Eur J Pediatr 1989;148:669–75.
   Google Scholar
• Decsi T, Koletzko B. Fatty acid composition of plasma lipid classes in healthy subject from birth to young adulthood. Eur J Pediatr 1994;153:520–5.
   PubMed Web of Science ®Google Scholar
• Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212–6.
   PubMed Web of Science ®Google Scholar
• Donovitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease. Gastroenterology 1985;88: 580–7.
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn’s colitis, and Clostridium difficile colitis. Gastroenterology 1988;95: 11–7.
   Google Scholar
• Wardle TD, Turnberg LA. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 1992;33:1644–51.
   PubMed Web of Science ®Google Scholar
• Rampton DS, Sladen GE, Youlten LJ. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis. Gut 1980;21: 591–6.
   Google Scholar
• Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 1991;32:1151–5.
   PubMed Web of Science ®Google Scholar
• Middleton SJ, Naylor S, Woolner J, Hunter JO. A doubleblind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther 2002;16: 1131–4.
   PubMed Web of Science ®Google Scholar
• Roberts WG, Simon TJ, Berlin RG, Haggitt RC, Snyder ES, Stenson WF, et al. Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology 1997;112:725–32.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Dube LM, Rountree LV, Linnen PJ, Lancaster JF. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group for ulcerative colitis. Gastroenterology 1997;112:718–24.
   Google Scholar
• Lapillonne A, Carlson SE. Polyunsaturated fatty acids and infant growth. Lipids 2001;36:901–11.
   PubMed Web of Science ®Google Scholar